We explore the emerging trend of patients bypassing traditional healthcare to obtain weight loss medications like Ozempic through unofficial channels and telehealth platforms. This underground movement raises serious ethical and legal concerns, as individuals manipulate systems to access these drugs without proper prescriptions, risking their health and undermining physicians' reputations.

Recent reports from The Atlantic and ABC News highlight the rise of "OZIC hackers" and Eli Lilly's decision to sell its new weight loss drug, Z-bound, directly to consumers. While this shift aims to increase accessibility, it poses significant risks, including potential misuse and adverse effects due to the lack of necessary medical evaluations.

As physicians face pressures to prescribe these drugs more liberally, they must navigate the balance between offering effective weight loss solutions and adhering to best practices and regulatory guidelines. The responsibility remains with healthcare providers to ensure patient safety amidst these changing dynamics.

Support the show